Help | RSS Feed



Vivus, Inc. (NASD:VVUS) Seasonal Chart

Seasonal Chart Analysis

Analysis of the Vivus, Inc. (NASD:VVUS) seasonal charts above shows that a Buy Date of February 11 and a Sell Date of June 5 has resulted in a geometric average return of 14.72% above the benchmark rate of the S&P 500 Total Return Index over the past 20 years. This seasonal timeframe has shown positive results compared to the benchmark in 16 of those periods. This is a very good rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 20 years by an average of 30.96% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

VIVUS Incis a biopharmaceutical company engaged in the
development and commercialization of therapeutic products for large underserved
markets. Its product line includes Qsymia for sleep apnea, STENDRA for erectile
dysfunction.

Stocks mentioned in this post:

    Search Seasonal Charts by Symbol, Company, or Term

   Symbols by Letter: A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z


Sponsored By...
Seasonal Advantage Portfolio by CastleMoore